Airway mucus in
cystic fibrosis (CF) is highly elastic, but the mechanism behind this pathology is unclear. We hypothesized that the biophysical properties of CF mucus are altered because of neutrophilic oxidative stress. Using confocal imaging, rheology, and biochemical measures of
inflammation and oxidation, we found that CF airway mucus
gels have a molecular architecture characterized by a core of
mucin covered by a web of
DNA and a rheological profile characterized by high elasticity that can be normalized by chemical reduction. We also found that high levels of
reactive oxygen species in CF mucus correlated positively and significantly with high concentrations of the oxidized products of
cysteine (
disulfide cross-links). To directly determine whether oxidation can cross-link
mucins to increase mucus elasticity, we exposed induced sputum from healthy subjects to oxidizing stimuli and found a marked and
thiol-dependent increase in sputum elasticity. Targeting
mucin disulfide cross-links using current
thiol-amino structures such as
N-acetylcysteine (NAC) requires high drug concentrations to have
mucolytic effects. We therefore synthesized a
thiol-
carbohydrate structure (methyl 6-thio-6-deoxy-α-D-galactopyranoside) and found that it had stronger reducing activity than NAC and more potent and fast-acting
mucolytic activity in CF sputum. Thus, oxidation arising from airway
inflammation or environmental exposure contributes to pathologic mucus gel formation in the lung, which suggests that it can be targeted by
thiol-modified
carbohydrates.